eClinical Insights, a provider of cloud-based clinical trials software, has announced the introduction of its eClinical intelligence platform, a cloud-based platform that provides real-time data insights for clinical trials. eClinical ...
Tags: Cloud-Based Platform, eClinical
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Novian Health, the developer of Novilase breast therapy, has announced the issuance of a new US patent covering the interstitial laser therapy in combination with interstitial brachytherapy treatment. Novian Health has developed the ...
Tags: Novian Health, Breast Cancer
Jarvik Heart, a manufacturer of cardiac assist devices, has announced the Shonin approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the Jarvik 2000 heart, a small left ventricular assist device implanted inside ...
HOUSTON — Mattress Firm has appointed industry veteran and philanthropist Roger Magowitz executive director of the Mattress Firm Foundation. He will oversee the day-to-day operations of the foundation, which raises awareness and funds ...
Tags: Mattress Firm, Roger Magowitz, Mattress Firm Foundation, appointment
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Bruin Biometrics has reported results from the two Institutional Review Board-approved clinical trials conducted with its SEM Scanner to detect pressure ulcers. SEM Scanner is a class IIA medical device developed by Bruin Biometrics in ...
Tags: Biometrics, Health, Medicine
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
VBL Therapeutics has secured fast track status from the US Food and Drug Administration (FDA) for its lead oncology drug VB-111, for prolongation of survival in patients with Recurrent Glioblastoma Multiforme (rGBM). VB-111 was already ...
The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
After 85 years, antibiotics are growing impotent. So what will medicine, agriculture and everyday life look like if we lose these drugs entirely? A few years ago, I started looking online to fill in chapters of my family history that no ...
Tags: imagining, post-antibiotics, future
Quadrant Engineering Plastic Products has announced the introduction of NONSPEC, a talented group of engineering students from the University of Massachusetts Lowell, who are developing breakthrough prosthetics technologies aimed at making ...
Tags: Quadrant Engineering, Medicine
Scanadu-a Silicon Valley-based startup seeking to commercialize a real-life version of a Star Trek tricorder- has recently raised $10.5 million in a Series A venture capital round, the company said Tuesday. The company is among the nearly ...
Tags: Scanadu, Tricorder Technology, Venture Capital Cash, Star Trek tricorder
The RNS device receiced FDA approval via the PMA pathway. NeuroPace (Mountain View, CA) landed FDA PMA approval for its RNS Stimulator, a device that can detect and treat patients suffering from drug-resistant epilepsy. Seizures occur ...
Tags: RNS, FDA approval, PMA pathway, NeuroPace